• Paul B Spiegel, Joseph G Cheaib, Saad Abdel Aziz, Orit Abrahim, Michael Woodman, Adam Khalifa, Minyoung Jang, and Farrah J Mateen.
• Department of International Health, Johns Hopkins University, Baltimore, MD, USA; Center for Humanitarian Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: pbspiegel@jhu.edu.
• Lancet Oncol. 2020 May 1; 21 (5): e280-e291.

AbstractProtracted conflicts in the Middle East have led to successive waves of refugees crossing borders. Chronic, non-communicable diseases are now recognised as diseases that need to be addressed in such crises. Cancer, in particular, with its costly, multidisciplinary care, poses considerable financial and ethical challenges for policy makers. In 2014 and with funding from the United Nations High Commissioner for Refugees, we reported on cancer cases among Iraqi refugees in Jordan (2010-12) and Syria (2009-11). In this Policy Review, we provide data on 733 refugees referred to the United Nations High Commissioner for Refugees in Lebanon (2015-17) and Jordan (2016-17), analysed by cancer type, demographic risk factors, treatment coverage status, and cost. Results show the need for increased funding and evidence-based standard operating procedures across countries to ensure that patients have equitable access to care. We recommend a holistic response to humanitarian crises that includes education, screening, treatment, and palliative care for refugees and nationals and prioritises breast cancer and childhood cancers.Copyright © 2020 Elsevier Ltd. All rights reserved.

35 keywords...

hide…